Alkermes just reported Q2 results, with progress around revenue growth from its product portfolio and some pipeline progress.

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 ...

Achieved Record Total Company Average Quarterly Production of 47,196 boepdFunds Flow From Operations(1) of $54 million, Adjusted EBITDA(1) of $77 million and Return to Free Cash FlowSigned Mandate ...

The global military wearables market, valued at approximately USD 3.10 billion in 2022, is projected to grow at a CAGR of more than 1.80% during the forecast period 2023-2030. Military wearables ...

Syensqo completes the third tranche of its €300 million Share Buyback Program Brussels, Belgium - July 30, 2025 17:45 CET Syensqo SA is pleased to announce the successful completion of the third ...

Record enterprise bookings of $5.6 billion, up 5 percent; organic bookings up 4 percent Bookings strength led by Americas Commercial HVAC applied solutions up over 60 percent GAAP continuing EPS of $3 ...